Related Experiment Video

Updated: Aug 18, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 4, 2014

Infant botulism. Epidemiological, clinical, and laboratory aspects

S S Arnon, T F Midura, S A Clay

    JAMA
    |May 2, 1977
    PubMed

    Insights

    Infant botulism may result from gastrointestinal production of Clostridium botulinum toxin after organism ingestion. This infectious disease in infants presents with weakness, cranial nerve deficits, and apnea, requiring further study for public health implications.

    Area of Science:

    • Microbiology
    • Pediatrics
    • Neurology

    Background:

    • Clostridium botulinum is an anaerobic bacterium producing a potent neurotoxin.
    • Infant botulism is a rare but serious condition affecting infants.
    • Previous understanding of infant botulism sources was limited.

    Purpose of the Study:

    • To identify the source of Clostridium botulinum toxin in infants with botulism.
    • To describe the clinical presentation and diagnostic findings in affected infants.
    • To investigate the potential for in vivo toxin production.

    Main Methods:

    • Fecal samples analyzed for Clostridium botulinum organisms and toxin.
    • Clinical histories and physical examinations documented.
    • Electromyography (EMG) performed to assess neuromuscular function.

    Main Results:

    • Clostridium botulinum organisms and toxin detected in feces of six infants (5-20 weeks old).
    • Clinical signs included constipation, weak sucking, cranial nerve deficits, weakness, and apnea.
    • Characteristic EMG pattern (brief, small, abundant, motor-unit action potentials - BSAP) observed.

    Conclusions:

    • In vivo (gastrointestinal) production of Clostridium botulinum toxin is a likely source in these infant cases.
    • This represents a newly recognized infectious disease in infants.
    • Further research is needed to understand the full spectrum, incidence, and public health impact.

    More Related Videos

    Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat08:27

    Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

    Published on: October 29, 2014

    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

    A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

    Published on: August 12, 2020

    Related Concept Videos

    Development of Human Microbiota01:30

    Development of Human Microbiota

    The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
    Development of the Oral Microbiota01:28

    Development of the Oral Microbiota

    The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
    Investigation of Disease Outbreaks01:23

    Investigation of Disease Outbreaks

    Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
    Botulism01:22

    Botulism

    Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...